找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Disease Recurrence After Liver Transplantation; Natural History, Tre Paul J. Thuluvath Book 2016 Springer Science+Business Media New York 2

[復(fù)制鏈接]
樓主: otitis-externa
11#
發(fā)表于 2025-3-23 11:14:35 | 只看該作者
12#
發(fā)表于 2025-3-23 14:28:59 | 只看該作者
13#
發(fā)表于 2025-3-23 19:12:16 | 只看該作者
14#
發(fā)表于 2025-3-23 22:22:50 | 只看該作者
15#
發(fā)表于 2025-3-24 03:28:08 | 只看該作者
Treatment of Recurrent Hepatitis C,e the natural history of recurrent hepatitis. Preliminary studies indicate that approximately 90 % of people with recurrent HCV could be cured with a combination of direct acting antiviral drugs with minimal side effects.
16#
發(fā)表于 2025-3-24 08:52:59 | 只看該作者
17#
發(fā)表于 2025-3-24 12:01:43 | 只看該作者
Recurrence of Primary Sclerosing Cholangitis After Liver Transplantation,s are limited for recurrent PSC. For these important entities affecting PSC patients after liver transplantation, we review the current published data on epidemiology, diagnostic criteria, risk factors, graft and patient survival, and treatment of recurrent PSC.
18#
發(fā)表于 2025-3-24 17:21:01 | 只看該作者
19#
發(fā)表于 2025-3-24 19:51:58 | 只看該作者
Recurrence of HCC When Transplanted Outside Milan Criteria,r LT. The main disadvantage of this set of criteria is that it is relatively restrictive. Several attempts have been made to expand these criteria to include tumors of greater number and size. The model for end-stage liver disease (MELD) prioritization system has utilized the Milan criteria since ad
20#
發(fā)表于 2025-3-24 23:09:01 | 只看該作者
Role of Neoadjuvant and Adjuvant Treatment in HCC Recurrence After Liver Transplantation, the Milan criteria have been shown to be 8–15 % and higher in those patients beyond the Milan criteria. The value of adjuvant therapy using systemic cytotoxic chemotherapy after LT has been disappointing. Sorafenib has been used for treatment in recurrent HCC after LT, and the data of safety and ef
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 22:42
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
伊川县| 黄龙县| 三门县| 平塘县| 秦安县| 宽甸| 汝阳县| 安泽县| 四会市| 娄烦县| 壶关县| 固原市| 新晃| 绵竹市| 嵊州市| 湄潭县| 库车县| 白银市| 黑龙江省| 宾阳县| 科技| 花莲市| 卢龙县| 姚安县| 方正县| 万载县| 清水河县| 津南区| 全椒县| 宜宾市| 饶阳县| 延津县| 吉隆县| 新河县| 闽清县| 井冈山市| 乐山市| 武山县| 神木县| 南汇区| 鄂伦春自治旗|